Tirzepatide

Tirzepatide is a groundbreaking dual-agonist research peptide that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors.

Note: Tirzepatide is for research purposes only and is not approved for human consumption or therapeutic use. All products are shipped in lyophilized form and must be reconstituted to a liquid for research and testing.  We are unable to provide any dosing instructions. All products should be considered pharmaceutical grade.